OTCMKTS:CZMWY Carl Zeiss Meditec (CZMWY) Stock Price, News & Analysis $36.20 -0.06 (-0.17%) As of 01:12 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendNews and Trends About Carl Zeiss Meditec Stock (OTCMKTS:CZMWY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Carl Zeiss Meditec alerts:Sign Up Key Stats Today's Range$36.17▼$36.8650-Day Range$33.27▼$37.9652-Week Range$26.65▼$55.94Volume217 shsAverage Volume4,134 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingStrong Sell Company Overview Carl Zeiss Meditec AG is a Germany-based medical technology company focused on ophthalmology and microsurgery. The company develops, manufactures and distributes diagnostic and therapeutic systems, surgical equipment, implants and related digital solutions for healthcare professionals. Its ophthalmic portfolio includes devices for eye examinations and diagnostics, laser systems for refractive and cataract procedures, surgical microscopes, intraocular lenses and other products used in cataract, retinal, glaucoma and corneal treatments. The company also supplies visualization systems and surgical microscopes for microsurgical procedures in areas such as neurosurgery, spine surgery and ear, nose and throat surgery. Carl Zeiss Meditec was established in 2002 through the combination of the ophthalmology activities of Carl Zeiss and Asclepion-Meditec. Headquartered in Jena, Germany, the company serves hospitals, clinics, ophthalmic practices and surgeons worldwide through its international sales and service organization. Markus Weber has served as the company’s chief executive officer since 2020.AI Generated. May Contain Errors. Read More Carl Zeiss Meditec Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks29th Percentile Overall ScoreCZMWY MarketRank™: Carl Zeiss Meditec scored higher than 29% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.5 / 5Analyst RatingStrong Sell Consensus RatingCarl Zeiss Meditec has received a consensus rating of Strong Sell. The company's average rating score is 1.40, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and 3 sell ratings.Amount of Analyst CoverageCarl Zeiss Meditec has only been the subject of 4 research reports in the past 90 days.Read more about Carl Zeiss Meditec's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth18.90% Earnings GrowthEarnings for Carl Zeiss Meditec are expected to grow by 18.90% in the coming year, from $1.27 to $1.51 per share.Read more about Carl Zeiss Meditec's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares ShortedShort Interest Ratio / Days to CoverCarl Zeiss Meditec has a short interest ratio ("days to cover") of 0.23, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Carl Zeiss Meditec has recently increased by 126.25%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCarl Zeiss Meditec does not currently pay a dividend.Dividend GrowthCarl Zeiss Meditec does not have a long track record of dividend growth. News and Social Media2.1 / 5News Sentiment0.33 News SentimentCarl Zeiss Meditec has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Carl Zeiss Meditec this week, compared to 0 articles on an average week. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Carl Zeiss Meditec insiders have not sold or bought any company stock.Percentage Held by InstitutionsCarl Zeiss Meditec has minimal institutional ownership at this time.Read more about Carl Zeiss Meditec's insider trading history. Receive CZMWY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CZMWY Stock News HeadlinesCarl Zeiss Meditec (OTCMKTS:CZMWY) Raised to Hold at Zacks ResearchOctober 8, 2026 | americanbankingnews.comCarl Zeiss: Recovery Has StartedAugust 19, 2026 | seekingalpha.comTomorrow, Wall Street goes home for two daysTomorrow at 4 PM Eastern, Wall Street closes for the weekend. Fund managers and billion-dollar accounts leave, but news doesn't. Contract announcements, FDA approvals, buyout rumors can hit smaller stocks all weekend with almost nobody watching until Monday. Millionaire trader Tim Sykes built a strategy around this gap, and he calls it the Weekend Gap.October 12 at 1:00 AM | Tim Sykes (Ad)Carl Zeiss Meditec AG (CZMWY) Q3 2026 Earnings Call TranscriptAugust 11, 2026 | seekingalpha.comCZMWY Share News TodayJune 22, 2026 | uk.investing.comCarl Zeiss Meditec AG (CZMWY) Q2 2026 Earnings Call TranscriptMay 13, 2026 | seekingalpha.comCarl Zeiss Meditec: Bad Optics But With 'Buy' PotentialApril 21, 2026 | seekingalpha.comCarl Zeiss Meditec: Hitting The BottomApril 21, 2026 | seekingalpha.comSee More Headlines CZMWY Stock Analysis - Frequently Asked Questions How have CZMWY shares performed this year? Carl Zeiss Meditec's stock was trading at $46.8470 at the beginning of the year. Since then, CZMWY shares have decreased by 22.0% and is now trading at $36.54. How do I buy shares of Carl Zeiss Meditec? Shares of CZMWY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today10/12/2026Next Earnings (Estimated)12/10/2026Fiscal Year End9/30/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:CZMWY CIKN/A Webwww.zeiss.com Phone493641220115FaxN/AEmployees5,784Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (OTCMKTS:CZMWY) was last updated on 10/12/2026 by MarketBeat.com Staff. From Our PartnersThe AI Infrastructure Play Kevin O'Leary Is BackingKevin O'Leary became a strategic investor in a NASDAQ-listed AI infrastructure company, calling it essentially...The Tomorrow Investor | SponsoredI have publicly predicted six major American crashes, before each one happened.Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredTomorrow, Wall Street goes home for two daysTomorrow at 4 PM Eastern, Wall Street closes for the weekend. Fund managers and billion-dollar accounts leave,...Tim Sykes | SponsoredFinally… options made simpleIan Cooper once believed successful options trading meant endless chart-watching, complex strategies, and big ...TradeWins | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredUrgent: Invest In ‘Elon’s iPhone’ Before July 22ndEarly Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredFree Ticker: Anthropic's silent partner could soar after record $2 trillion IPOAnthropic's IPO prospectus just leaked, revealing 261 pages tied to a record $2 trillion valuation. Beyond ...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carl Zeiss Meditec AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Carl Zeiss Meditec With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
